These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 32886425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
    Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L.
    Lancet Oncol; 2017 Jan; 18(1):63-74. PubMed ID: 27914822
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Special considerations in the design and implementation of pediatric otoprotection trials.
    Freyer DR, Orgel E, Knight K, Krailo M.
    J Cancer Surviv; 2023 Feb; 17(1):4-16. PubMed ID: 36637630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
    Viglietta V, Shi F, Hu QY, Ren Y, Keilty J, Wolff H, McCarthy R, Kropp J, Weber P, Soglia J.
    Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugières L, Perilongo G, Czauderna P, Morland B, Neuwelt EA.
    N Engl J Med; 2018 Jun 21; 378(25):2376-2385. PubMed ID: 29924955
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.
    Orgel E, Knight KR, Chi YY, Malvar J, Rushing T, Mena V, Eisenberg LS, Rassekh SR, Ross CJD, Scott EN, Neely M, Neuwelt EA, Muldoon LL, Freyer DR.
    Clin Cancer Res; 2023 Jul 05; 29(13):2410-2418. PubMed ID: 37134194
    [Abstract] [Full Text] [Related]

  • 16. Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.
    Brock P, Meijer A, Kogner P, Ansari M, Capra M, Geller J, Heuvel-Eibrink MVD, Knight K, Kruger M, Lindemulder S, Maibach R, O'Neill A, Papadakis V, Rajput K, Bleyer A, Bouffet E, Sullivan M.
    Pediatr Blood Cancer; 2023 May 05; 70(5):e30248. PubMed ID: 36772889
    [No Abstract] [Full Text] [Related]

  • 17. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
    Freyer DR, Brock P, Knight K, Reaman G, Cabral S, Robinson PD, Sung L.
    Lancet Child Adolesc Health; 2019 Aug 05; 3(8):578-584. PubMed ID: 31160205
    [Abstract] [Full Text] [Related]

  • 18. Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.
    Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR.
    Cancer Med; 2018 Jul 05; 7(7):2951-2959. PubMed ID: 29846043
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
    Ishikawa E, Sugimoto H, Hatano M, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N, Murono S, Ito M, Yoshizaki T.
    Acta Otolaryngol; 2015 Sep 05; 135(9):919-24. PubMed ID: 25861690
    [Abstract] [Full Text] [Related]

  • 20. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
    Neuwelt EA, Brummett RE, Doolittle ND, Muldoon LL, Kroll RA, Pagel MA, Dojan R, Church V, Remsen LG, Bubalo JS.
    J Pharmacol Exp Ther; 1998 Jul 05; 286(1):77-84. PubMed ID: 9655844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.